This is a rare tumour of the lung. Rarely, similar tumours have been described at a wide range of extrapulmonary sites. Clear cell tumour of the lung is thought to be one of a family of tumours with the features of so-called perivascular epithelioid cells (PEC)2. Rarely, a combination of clear cell tumour, lymphangioleiomyomatosis multifocal multinodular pneumocyte hyperplasia and tuberous sclerosis has been reported3.
Epidemiology
The age range is very wide, including children. Only very rarely is there an association with tuberous sclerosis
Radiology
Lesions are usually solitary and peripheral.
Histopathology
Cells have abundant clear or eosinophilic cytoplasm, usually but not always containing glycogen7. Cell borders are distinct. There are thin-walled sinusoidal vessels7. Mitoses are usually absent and necrosis is rare1. Cases with a component of adipocytes have been reported2.
Immunohistochemistry
positive, 7/95, 4/56, 2/27 |
|
HMB-50 |
positive, 6/95 |
Cathepsin B |
5/56 |
4/56 |
|
may be focally positive |
|
may be focally positive |
|
may be focally positive, 9/95, 1/56 |
|
may be focally positive, 9/95, 3/56 |
|
may be focally positive, 2/27 |
|
HAM56 |
2/56 |
0/27 |
|
2/56 |
|
0/84, 0/56, 0/27 |
|
0/84 |
|
0/56 |
|
0/84, 0/56 |
|
1/84, 0/56 |
|
1/84 |
|
0/84, 4/56, 2/27 |
|
0/27 |
|
0/95, 0/56 |
|
0/56 |
|
Ultrastructure
There is abundant glycogen1. Premelanosomes may be seen5.
Differential diagnosis
primary clear cell carcinoma: negative for HMB-45 and positive for cytokeratins.
metastatic renal cell carcinoma
granular cell tumour: positive for S-100 but not for HMB-45 and lacks abundant glycogen.
metastatic melanoma and clear cell sarcoma: also positive for HMB-45 but show nuclear atypia.
Prognosis
Benign: cured by local resection. There are rare reports of malignant metastasizing cases1.
References
Diagnostic histopathology of tumors. Edited by CDM Fletcher. 2nd edition. Churchill Livingstone. Page 195.
0 Tumours of the Lung, Pleura, Thymus and Heart. WHO Classification of Tumours. IARC Press 2004.
8 Hornick JL,Fletcher CD. PEComa: what do we know so far? Histopathology 2006; 48:75-82
This page last revised 1.2.2006.
©SMUHT/PW Bishop